Orgabio Holdings Berhad (KLSE:ORGABIO)

Verve Therapeutics Ratios and Metrics

Market cap in millions MYR. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 28, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	79	99	71	-	-	-
Market Cap Growth	24.56%	40.35%	-	-	-	-
Enterprise Value	83	96	61	-	-	-
Last Close Price	0.32	0.40	0.28	-	-	-
PE Ratio	18.01	24.13	-	-	-	-
Forward PE	-	16.14	16.14	-	-	-
PS Ratio	0.81	1.34	1.20	-	-	-
PB Ratio	1.34	1.78	1.37	-	-	-
P/TBV Ratio	1.34	1.78	1.37	-	-	-
P/OCF Ratio	21.55	23.39	-	-	-	-
PEG Ratio	-	1.13	1.13	-	-	-
EV/Sales Ratio	0.85	1.29	1.04	-	-	-
EV/EBITDA Ratio	9.83	13.76	32.82	-	-	-
EV/EBIT Ratio	13.30	18.14	376.15	-	-	-
Debt / Equity Ratio	0.18	0.17	0.21	0.52	0.56	0.86
Debt / EBITDA Ratio	1.27	1.27	3.85	1.23	0.82	1.34
Debt / FCF Ratio	-	-	-	-	1.49	1.60
Asset Turnover	1.18	1.01	1.01	1.44	1.41	1.02
Inventory Turnover	4.81	5.00	5.48	7.78	8.91	6.65
Quick Ratio	1.06	1.84	3.36	0.94	1.48	1.17
Current Ratio	1.96	2.94	4.64	1.89	2.11	1.46
Return on Equity (ROE)	7.73%	7.65%	-2.33%	25.71%	42.56%	38.04%
Return on Assets (ROA)	4.68%	4.50%	0.18%	11.10%	18.33%	13.13%
Return on Capital (ROIC)	5.79%	5.16%	0.21%	14.40%	25.49%	18.17%
Return on Capital Employed (ROCE)	9.20%	8.20%	0.30%	23.10%	39.30%	30.50%
Earnings Yield	5.55%	4.14%	-1.25%	-	-	-
FCF Yield	-6.28%	-4.63%	-14.69%	-	-	-
Payout Ratio	-	-	-	43.40%	91.62%	-
Buyback Yield / Dilution	0.39%	-0.43%	-94.71%	-13478.87%	-2.37%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.